SIC
BEAM icon

SJS Investment Consulting’s Beam Therapeutics BEAM Stock Holding History

SJS Investment Consulting’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2K Buy
35
+32
+1,067% +$966 ﹤0.01% 1963
2026
Q1 		$72 Hold
3
– – ﹤0.01% 2190
2025
Q4 		$84 Buy
+3
New +$77 ﹤0.01% 1964
2025
Q2 		– Sell
-5
Closed -$98 – 1567
2025
Q1 		$98 Hold
5
– – ﹤0.01% 1523
2024
Q4 		$124 Buy
5
+3
+150% +$77 ﹤0.01% 1507
2024
Q3 		$49 Hold
2
– – ﹤0.01% 1621
2024
Q2 		$47 Buy
+2
New +$49 ﹤0.01% 1623

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

SJS Investment Consulting's BEAM Position: Q2 2026 in Review

SJS Investment Consulting increased its Beam Therapeutics (BEAM) stake by 1,067% in Q2 2026, buying an estimated $966 and bringing the position to 35 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1963.

SJS Investment Consulting first reported a position in BEAM in Q2 2024 and has held it in 7 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • SJS Investment Consulting held 35 shares of Beam Therapeutics worth $1.2K as of Q2 2026.
  • SJS Investment Consulting bought 32 Beam Therapeutics shares in Q2 2026, an estimated $966.
  • Beam Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1963 holding.
  • SJS Investment Consulting first reported a position in Beam Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.